1. A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity;Adjei;Cancer Res.,2000
2. Genistein, an inhibitor of tyrosine specific protein kinases;Akiyama;J. Biol. Chem.,1987
3. Dose-dependent pharmacokinetics of a chimerised monoclonal antibody (C225) against EGFR;Anderson;Proc. Am. Assoc. Cancer Res.,1998
4. 99mTc-sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumors;Bakker;Anticancer Res.,1999
5. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neuoverexpressing metastatic breast cancer;Baselga;Sem. Oncol.,1999